6:08 PM
 | 
Nov 02, 2012
 |  BC Extra  |  Top Story

EC approves gene therapy Glybera

The European Commission approved Glybera alipogene tiparvovec from uniQure B.V. (Amsterdam, the Netherlands) to treat lipoprotein lipase (LPL) deficiency in patients with recurring, acute pancreatitis. Glybera is the first gene therapy approved outside of China. The company plans to scale up manufacturing for...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >